|
|
||||||||
Letters to the Editor |
a Department of Physiology, School of Biomedical Sciences, University of Liverpool, Liverpool L69 3BX, UK
b Department Human Anatomy & Cell Biology, School of Biomedical Sciences, University of Liverpool, Liverpool L69 3GE, UK
Received 16 February 2009; accepted 18 February 2009.
* Corresponding author. Tel.: +44 151 7945510; fax: +44 151 7945517. (Email: conant{at}liv.ac.uk).
Key Words: Arteries CABG arterial grafts CABG pharmacology/physiology Rho-kinase
We very much appreciate the comments by Sadaba [1] and he is correct to highlight the importance of the rho-kinase pathway. From the data presented in our paper [2] and that from earlier studies on the actions of phenoxybenzamine [3,4] it is clear that should an irreversible inhibitor of rho-kinase become available it would represent an ideal candidate for the topical treatment of arterial bypass grafts.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |